CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ADAMAS PHARMACEUTICALS INC ownership

ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 66 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ADAMAS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$88,000
-7.4%
17,8730.0%0.00%
Q2 2021$95,000
+10.5%
17,8730.0%0.00%
Q1 2021$86,000
+10.3%
17,8730.0%0.00%
Q4 2020$78,000
+5.4%
17,8730.0%0.00%
Q3 2020$74,000
-46.0%
17,873
-62.2%
0.00%
Q1 2020$137,000
-23.0%
47,230
+0.6%
0.00%
Q4 2019$178,000
-26.1%
46,9280.0%0.00%
Q3 2019$241,000
-17.2%
46,9280.0%0.00%
Q2 2019$291,000
-4.0%
46,928
+10.3%
0.00%
Q1 2019$303,000
-29.7%
42,547
-15.6%
0.00%
Q4 2018$431,000
-55.7%
50,432
+3.9%
0.00%
-100.0%
Q3 2018$972,000
-23.0%
48,542
-0.6%
0.00%0.0%
Q2 2018$1,262,000
+48.6%
48,857
+37.7%
0.00%0.0%
Q1 2018$849,000
-18.4%
35,490
+15.6%
0.00%0.0%
Q4 2017$1,041,000
+78.9%
30,690
+11.7%
0.00%0.0%
Q3 2017$582,000
+21.0%
27,4720.0%0.00%
Q2 2017$481,0000.0%27,4720.0%0.00%
Q1 2017$481,000
+3.4%
27,4720.0%0.00%
-100.0%
Q4 2016$465,000
+3.1%
27,4720.0%0.00%0.0%
Q3 2016$451,000
+8.4%
27,4720.0%0.00%0.0%
Q2 2016$416,000
+40.1%
27,472
+34.2%
0.00%
Q1 2016$297,000
-26.7%
20,472
+43.4%
0.00%
-100.0%
Q4 2015$405,000
+69.5%
14,2720.0%0.00%
Q3 2015$239,000
-36.3%
14,2720.0%0.00%
-100.0%
Q2 2015$375,00014,2720.00%
Other shareholders
ADAMAS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 984,329$6,999,0004.03%
Broadfin Capital, LLC 2,469,894$17,561,0003.63%
Healthcare Value Capital, LLC 100,000$711,0002.74%
ARMISTICE CAPITAL, LLC 2,744,000$19,510,0001.07%
DELTEC ASSET MANAGEMENT LLC 536,836$3,817,0000.84%
SECTORAL ASSET MANAGEMENT INC 808,924$5,751,0000.69%
Mosaic Family Wealth, LLC 91,314$649,0000.26%
Worth Venture Partners, LLC 59,740$425,0000.24%
EMERALD ADVISERS, LLC 626,247$4,453,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 565,319$4,019,0000.16%
View complete list of ADAMAS PHARMACEUTICALS INC shareholders